The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral accounting for % of the Gamma-aminobutyric Acid (GABA) Receptor Agonist global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is valued at US$ million in 2021, while the North America and Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market.
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Scope and Market Size
Gamma-aminobutyric Acid (GABA) Receptor Agonist market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Parenteral
Intrathecal
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
Market Analysis and Insights: Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral accounting for % of the Gamma-aminobutyric Acid (GABA) Receptor Agonist global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is valued at US$ million in 2021, while the North America and Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market.
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Scope and Market Size
Gamma-aminobutyric Acid (GABA) Receptor Agonist market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Parenteral
Intrathecal
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Intrathecal
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Perspective (2017-2028)
2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Growth Trends by Region
2.2.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Region (2017-2022)
2.2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Region (2023-2028)
2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics
2.3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Industry Trends
2.3.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
2.3.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
2.3.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue
3.1.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue (2017-2022)
3.1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Players (2017-2022)
3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue
3.4 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio
3.4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2021
3.5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Key Players Head office and Area Served
3.6 Key Players Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Solution and Service
3.7 Date of Enter into Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Type
4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Type (2017-2022)
4.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Type (2023-2028)
5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Application
5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Application (2017-2022)
5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
6.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
6.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
7.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
7.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
8.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
8.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
9.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
9.3 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
10.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
10.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.1.4 Sanofi Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Detail
11.2.2 Mylan N.V. Business Overview
11.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.2.4 Mylan N.V. Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.2.5 Mylan N.V. Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Detail
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.4.4 Novartis Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Aytu BioScience
11.5.1 Aytu BioScience Company Detail
11.5.2 Aytu BioScience Business Overview
11.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.5.4 Aytu BioScience Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.5.5 Aytu BioScience Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Detail
11.6.2 Dr. Reddy’s Laboratories Business Overview
11.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.6.4 Dr. Reddy’s Laboratories Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Detail
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.7.4 Endo Pharmaceuticals Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Lupin
11.8.1 Lupin Company Detail
11.8.2 Lupin Business Overview
11.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.8.4 Lupin Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.8.5 Lupin Recent Development
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Detail
11.9.2 Johnson & Johnson Services Business Overview
11.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.9.4 Johnson & Johnson Services Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.9.5 Johnson & Johnson Services Recent Development
11.10 Lannett
11.10.1 Lannett Company Detail
11.10.2 Lannett Business Overview
11.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.10.4 Lannett Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.10.5 Lannett Recent Development
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Company Detail
11.11.2 Sun Pharmaceutical Industries Business Overview
11.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.11.4 Sun Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.11.5 Sun Pharmaceutical Industries Recent Development
11.12 Cipla
11.12.1 Cipla Company Detail
11.12.2 Cipla Business Overview
11.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.12.4 Cipla Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.12.5 Cipla Recent Development
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Detail
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.13.4 Aurobindo Pharma Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.13.5 Aurobindo Pharma Recent Development
11.14 Zydus Cadila
11.14.1 Zydus Cadila Company Detail
11.14.2 Zydus Cadila Business Overview
11.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.14.4 Zydus Cadila Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.14.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Key Players of Intrathecal
Table 5. Key Players of Others
Table 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2017-2022)
Table 10. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2023-2028)
Table 12. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends
Table 13. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
Table 14. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
Table 15. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
Table 16. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Players (2017-2022)
Table 18. Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2021)
Table 19. Ranking of Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Solution and Service
Table 23. Date of Enter into Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type (2017-2022)
Table 27. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type (2023-2028)
Table 29. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application (2017-2022)
Table 31. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application (2023-2028)
Table 33. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028) & (US$ Million)
Table 43. Sanofi Company Detail
Table 44. Sanofi Business Overview
Table 45. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 46. Sanofi Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 47. Sanofi Recent Development
Table 48. Mylan N.V. Company Detail
Table 49. Mylan N.V. Business Overview
Table 50. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 51. Mylan N.V. Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 52. Mylan N.V. Recent Development
Table 53. Teva Pharmaceutical Industries Company Detail
Table 54. Teva Pharmaceutical Industries Business Overview
Table 55. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 56. Teva Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 57. Teva Pharmaceutical Industries Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 61. Novartis Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Aytu BioScience Company Detail
Table 64. Aytu BioScience Business Overview
Table 65. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 66. Aytu BioScience Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 67. Aytu BioScience Recent Development
Table 68. Dr. Reddy’s Laboratories Company Detail
Table 69. Dr. Reddy’s Laboratories Business Overview
Table 70. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 71. Dr. Reddy’s Laboratories Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 72. Dr. Reddy’s Laboratories Recent Development
Table 73. Endo Pharmaceuticals Company Detail
Table 74. Endo Pharmaceuticals Business Overview
Table 75. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 76. Endo Pharmaceuticals Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 77. Endo Pharmaceuticals Recent Development
Table 78. Lupin Company Detail
Table 79. Lupin Business Overview
Table 80. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 81. Lupin Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 82. Lupin Recent Development
Table 83. Johnson & Johnson Services Company Detail
Table 84. Johnson & Johnson Services Business Overview
Table 85. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 86. Johnson & Johnson Services Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 87. Johnson & Johnson Services Recent Development
Table 88. Lannett Company Detail
Table 89. Lannett Business Overview
Table 90. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
Table 91. Lannett Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 92. Lannett Recent Development
Table 93. Sun Pharmaceutical Industries Company Detail
Table 94. Sun Pharmaceutical Industries Business Overview
Table 95. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor AgonistProduct
Table 96. Sun Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 97. Sun Pharmaceutical Industries Recent Development
Table 98. Cipla Company Detail
Table 99. Cipla Business Overview
Table 100. Cipla Gamma-aminobutyric Acid (GABA) Receptor AgonistProduct
Table 101. Cipla Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 102. Cipla Recent Development
Table 103. Aurobindo Pharma Company Detail
Table 104. Aurobindo Pharma Business Overview
Table 105. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor AgonistProduct
Table 106. Aurobindo Pharma Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 107. Aurobindo Pharma Recent Development
Table 108. Zydus Cadila Company Detail
Table 109. Zydus Cadila Business Overview
Table 110. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor AgonistProduct
Table 111. Zydus Cadila Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022) & (US$ Million)
Table 112. Zydus Cadila Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Intrathecal Features
Figure 5. Others Features
Figure 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Gamma-aminobutyric Acid (GABA) Receptor Agonist Report Years Considered
Figure 11. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region: 2021 VS 2028
Figure 14. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Players in 2021
Figure 15. Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2021
Figure 17. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2017-2028)
Figure 19. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2017-2028)
Figure 23. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2017-2028)
Figure 31. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2017-2028)
Figure 39. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2017-2028)
Figure 43. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 46. Mylan N.V. Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 47. Teva Pharmaceutical Industries Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 48. Novartis Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 49. Aytu BioScience Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 50. Dr. Reddy’s Laboratories Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 51. Endo Pharmaceuticals Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 52. Lupin Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 53. Johnson & Johnson Services Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 54. Lannett Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 56. Cipla Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 57. Aurobindo Pharma Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 58. Zydus Cadila Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
